We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Implantable System Modulates Cardiac Contractions

By HospiMedica International staff writers
Posted on 02 Apr 2019
Print article
Image: The Optimizer Smart implantable device (Photo courtesy of Impulse Dynamics).
Image: The Optimizer Smart implantable device (Photo courtesy of Impulse Dynamics).
A novel device delivers non-excitatory electrical pulses to improve systolic contractions in severe and chronic heart failure (HF) patients.

The Impulse Dynamics (Stuttgart, Germany) Optimizer Smart implantable device works by delivering cardiac contractility modulation (CCM) signals to the heart muscle during the absolute refractory period (just after the heart’s excitation), initiating biochemical and neurohormonal changes in the myocardium. As a result, the myocardium contracts more, with no associated increase in oxygen consumption, enabling the heart to operate more efficiently. The target population includes HF patients with a reduced ejection fraction who are in normal sinus rhythm, and are not indicated for a cardiac resynchronization therapy (CRT) device.

The system includes an implantable pulse generator (IPG) unit that both senses the heart’s electrical activity and delivers CCM signals via two electrodes placed in the right ventricle. The IPG is recharged (without supervision) weekly using a home-based charger that also provides instructions and feedback to the patient on the charging process. A portable programmer allows medical personnel to customize and optimize signal parameters according to individual patient needs, with dynamic evaluations made using the patient’s electrocardiogram (ECG) and marker channels.

”CCM technology meets a major need globally, and we are committed to demonstrating the value of CCM therapy to healthcare systems worldwide to benefit more patients with heart failure,” said Simos Kedikoglou, MD, CEO of Impulse Dynamics. “We are extremely excited that the Optimizer Smart System with CCM therapy is now available in the United States. We look forward to growing our commercial presence in the US and globally.”

“We finally have available an effective device-based therapy for advanced heart failure patients with mildly to moderately reduced left ventricular ejection fractions who are not eligible for CRT,” said Professor William Abraham, MD, of Ohio State University (OSU, Columbus, USA). “The Optimizer System, along with guideline-directed medical therapies, can improve the lives of many heart failure patients in the US who previously did not have access to this therapy. As such, it represents a real game-changer for these patients.”

Related Links:
Impulse Dynamics

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Hysteroscopic Fluid Management System
HysteroFlow/HysteroBalance II

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.